This Article Full Text (PDF) Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by MacMillan, J. C. Articles by Williams, E. D. Search for Related Content PubMed PubMed Citation Articles by MacMillan, J. C. Articles by Williams, E. D.

Technetium-99m Medronate uptake in subcutaneous soft-tissue nodules in a patient with renal failure and renal adenocarcinoma

Renal Unit, Royal Infirmary, Sunderland District General Hospital, Sunderland, Tyne and Wear ^* Regional Medical Physics Department, Sunderland District General Hospital, Sunderland, Tyne and Wear

This excerpt was created in the absence of an abstract.

Subcutaneous heparin preparations are often used for prophylaxis of post-operative deep venous thrombosis. We report a case in which uptake of the bone scanning agent ⁹⁹Tc^m methylene diphosphonate (Medronate) into subcutaneous heparin injection sites misleadingly suggested metastases from a renal adenocarcinoma.

A 45-year-old man with adult polycystic kidney disease reached end-stage renal failure. Thrice weekly hospital haemodialysis via radial arterio-venous fistula was the chosen method of treatment. During the following 7 months he suffered recurrent right loin pain with associated urinary tract infections and two episodes of bacteriologically confirmed septicaemia. Table I shows his pre-dialysis biochemical values during this time. Before including him in the UK Transplant Programme it was decided to remove the right kidney.

Received for publication October 1, 1985.